{
    "medicine_id": "0446b08c93dbd1664e0e7d6f69c0df74cabdee13",
    "platform_id": "DB05064",
    "metadata": {
        "name": "Arcapta Neohaler 75 ug 1 Capsule",
        "composition": "75 ug 1 INCB13739",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in diabetes mellitus type 2 and diabetes prevention",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "11beta HSD1 is an enzyme that converts cortisone into the potent biologically active hormone cortisol This conversion occurs intra cellularly within several key metabolic tissues including the liver adipose muscle and pancreas Cortisol acts as an antagonist of insulin action and 11beta HSD1 mediated production of cortisol has been hypothesized to contribute to human insulin resistance and type 2 diabetes INCB13739 inhibits 11beta HSD1 and has the potential to provide a broad spectrum impact on the multiple components seen in patients with type 2 diabetes",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}